COGNITION THERAPEUTICS INC — Director's Dealing 2021

Oct 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COGNITION THERAPEUTICS INC (CGTX)
CIK: 0001455365
Period of Report: 2021-10-07

Reporting Person: O'Brien James Michael (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-07	Stock Option (right to buy)	$12	A	54457	Acquired	2031-10-07	Common Stock (54457)	Direct

Footnotes

F1: 25% of the shares of common stock underlying the option vest on the first anniversary of the closing of the issuer's initial public offering. The remaining shares underlying the option vest in equal monthly installments thereafter for thirty-six (36) months, on the last day of each such month.